D-Cycloserine - 98%, high purity , CAS No.68-41-7

1 Citations
Item Number
C108718
Grouped product items
SKUSizeAvailabilityPrice Qty
C108718-1g
1g
In stock
$9.90
C108718-5g
5g
In stock
$24.90
C108718-25g
25g
In stock
$79.90
C108718-100g
100g
Available within 4-8 weeks(?)
Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!
$229.90

NMDA glycine site agonist

Basic Description

Synonymsalpha-Cycloserine | (+)-4-Amino-3-isoxazolidinone | orientomycin | cycloserine | Miroseryn | Cyclo-D-serine | Tisomycin | D-4-amino-3-isoxazolidinone | Cycloserinum | Closina | Farmiserina | Seromycin | Wasserina | Cicloserina | Cyclorin
Specifications & PurityMoligand™, ≥98%
Biochemical and Physiological MechanismsMode of Action: Inhibits cell wall biosynthesis (D-Ala peptide bond formation). Also prevents conversion of D-Ala to L-Ala. Bacteriostatic. Mode of Resistance: D-Ala transport interference. Partial agonist at the glycine modulatory site of NMDA glutamater
Storage TempStore at -20°C,Argon charged
Shipped InIce chest + Ice pads
GradeMoligand™
NoteWherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20°C. Generally, these will be useable for up to one month. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour. Need more advice on solubility, usage and handling? Please visit our frequently asked questions (FAQ) page for more details.

Product Properties

ALogP-1.5

Associated Targets(Human)

CYP1A2 Tchem Cytochrome P450 1A2 (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
CYP2D6 Tclin Cytochrome P450 2D6 (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
CYP2C19 Tchem Cytochrome P450 2C19 (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
DRD1 Tclin D(1A) dopamine receptor (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
CYP3A4 Tclin Cytochrome P450 3A4 (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
ERVV-2 Tdark Endogenous retrovirus group V member 2 Env polyprotein (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
ESR1 Tclin Estrogen receptor (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
GABRA1 Tclin Gamma-aminobutyric acid receptor subunit alpha-1 (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
EHMT2 Tchem Histone-lysine N-methyltransferase EHMT2 (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
CBX1 Tbio Chromobox protein homolog 1 (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
CYP2C9 Tchem Cytochrome P450 2C9 (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
RUNX1 Tbio Runt-related transcription factor 1 (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
SLC36A1 Tchem Proton-coupled amino acid transporter 1 (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
HRH3 Tclin Histamine H3 receptor (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
HIF1A Tchem Hypoxia-inducible factor 1-alpha (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
KMT2A Tchem Histone-lysine N-methyltransferase 2A (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
HDAC6 Tclin Histone deacetylase 6 (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
TXNRD1 Tclin Thioredoxin reductase 1, cytoplasmic (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
SLC6A2 Tclin Sodium-dependent noradrenaline transporter (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
SLC6A3 Tclin Sodium-dependent dopamine transporter (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
SLC6A4 Tclin Sodium-dependent serotonin transporter (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
TSHR Tclin Thyrotropin receptor (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
PGR Tclin Progesterone receptor (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
PDE3A Tclin cGMP-inhibited 3',5'-cyclic phosphodiesterase A (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
PTGS1 Tclin Prostaglandin G/H synthase 1 (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
PDE4A Tclin cAMP-specific 3',5'-cyclic phosphodiesterase 4A (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
RGS4 Tchem Regulator of G-protein signaling 4 (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
DRD3 Tclin D(3) dopamine receptor (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
KDR Tclin Vascular endothelial growth factor receptor 2 (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
TDP1 Tchem Tyrosyl-DNA phosphodiesterase 1 (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
CHRM2 Tclin Muscarinic acetylcholine receptor M2 (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
ACHE Tclin Acetylcholinesterase (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
ABCB11 Tchem Bile salt export pump (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
CHRM1 Tclin Muscarinic acetylcholine receptor M1 (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
ADRA2A Tclin Alpha-2A adrenergic receptor (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
ADRA1A Tclin Alpha-1A adrenergic receptor (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
AR Tclin Androgen receptor (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
MAOA Tclin Amine oxidase [flavin-containing] A (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
HTR1A Tclin 5-hydroxytryptamine receptor 1A (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
ADORA3 Tchem Adenosine receptor A3 (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
HTR2B Tclin 5-hydroxytryptamine receptor 2B (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
TBXA2R Tclin Thromboxane A2 receptor (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
F2 Tclin Prothrombin (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
KCNH2 Tclin Potassium voltage-gated channel subfamily H member 2 (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
OPRM1 Tclin Mu-type opioid receptor (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
GRIN1 Tclin Glutamate receptor ionotropic, NMDA 1 (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
MAPK1 Tchem Mitogen-activated protein kinase 1 (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
GRIN2C Tclin Glutamate receptor ionotropic, NMDA 2C (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
F2 Tclin Thrombin (11687 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ESR1 Tclin Estrogen receptor alpha (17718 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PGR Tclin Progesterone receptor (8562 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CHRM2 Tclin Muscarinic acetylcholine receptor M2 (10671 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HTR1A Tclin Serotonin 1a (5-HT1a) receptor (14969 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRA2A Tclin Alpha-2a adrenergic receptor (9450 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AR Tclin Androgen Receptor (11781 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CHRM1 Tclin Muscarinic acetylcholine receptor M1 (12690 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TSHR Tclin Thyroid stimulating hormone receptor (29986 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MAOA Tclin Monoamine oxidase A (11911 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DRD1 Tclin Dopamine D1 receptor (9720 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ACHE Tclin Acetylcholinesterase (18204 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PTGS1 Tclin Cyclooxygenase-1 (9233 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SLC6A2 Tclin Norepinephrine transporter (10102 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SLC6A4 Tclin Serotonin transporter (12625 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRA1A Tclin Alpha-1a adrenergic receptor (8359 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
OPRM1 Tclin Mu opioid receptor (19785 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DRD3 Tclin Dopamine D3 receptor (14368 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SLC6A3 Tclin Dopamine transporter (10535 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GRIN1 Tclin Glutamate (NMDA) receptor subunit zeta 1 (122 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KCNH2 Tclin HERG (29587 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PDE3A Tclin Phosphodiesterase 3A (3309 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HTR2B Tclin Serotonin 2b (5-HT2b) receptor (10323 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TBXA2R Tclin Thromboxane A2 receptor (5717 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PDE4A Tclin Phosphodiesterase 4A (1943 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADORA3 Tchem Adenosine A3 receptor (15931 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HRH3 Tclin Histamine H3 receptor (10389 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KDR Tclin Vascular endothelial growth factor receptor 2 (20924 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP2D6 Tclin Cytochrome P450 2D6 (33882 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP1A2 Tchem Cytochrome P450 1A2 (26471 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP2C9 Tchem Cytochrome P450 2C9 (32119 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP2C19 Tchem Cytochrome P450 2C19 (29246 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP3A4 Tclin Cytochrome P450 3A4 (53859 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GRIN2C Tclin Glutamate [NMDA] receptor subunit epsilon 3 (47 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Homo sapiens (32628 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HIF1A Tchem Hypoxia-inducible factor 1 alpha (6027 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HSD17B10 Tchem Endoplasmic reticulum-associated amyloid beta-peptide-binding protein (20669 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ABCB11 Tchem Bile salt export pump (2311 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
EHMT2 Tchem Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 (93046 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TDP1 Tchem Tyrosyl-DNA phosphodiesterase 1 (345557 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SMN1 Tchem Survival motor neuron protein (34246 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
LMNA Tbio Prelamin-A/C (36751 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BLM Tchem Bloom syndrome protein (4248 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CBX1 Tbio Chromobox protein homolog 1 (92434 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MPHOSPH8 Tbio M-phase phosphoprotein 8 (656 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
RGS4 Tchem Regulator of G-protein signaling 4 (13867 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SLC36A1 Tchem Proton-coupled amino acid transporter 1 (102 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MEN1 Tchem Menin/Histone-lysine N-methyltransferase MLL (48157 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
RUNX1 Tbio Runt-related transcription factor 1/Core-binding factor subunit beta (7867 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GABRA1 Tclin Gamma-aminobutyric acid receptor subunit alpha-1/alpha-2/beta-2/gamma-2 (1034 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

ddlB D-alanylalanine synthetase (66 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
alr Alanine racemase (2 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
lpxC UDP-3-O-acyl-GlcNAc deacetylase (700 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mapk1 MAP kinase ERK2 (650 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Hdac6 Histone deacetylase 6 (222 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
murF UDP-N-acetylmuramoyl-tripeptide--D-alanyl-D-alanine ligase (21 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Providencia alcalifaciens (7 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Pseudomonas aeruginosa (123386 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Enterobacter cloacae (7976 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Klebsiella pneumoniae (43867 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Providencia rettgeri (925 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Serratia liquefaciens (11 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Staphylococcus aureus (210822 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Acinetobacter baumannii (41033 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Citrobacter freundii (1864 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Escherichia coli (133304 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Serratia marcescens (3237 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Chlamydia trachomatis (699 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Enterococcus faecium (13803 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Bacillus subtilis (32866 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mycobacterium avium (4587 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mycolicibacterium fortuitum (1335 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mycobacterium tuberculosis (203094 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Enterococcus faecalis (29875 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mycolicibacterium smegmatis (8003 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Plasmodium falciparum (966862 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Cryptococcus neoformans (21258 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Candida albicans (78123 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mus musculus (284745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Vero (26788 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
rep Replicase polyprotein 1ab (378 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
pfk 6-phospho-1-fructokinase (7870 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Txnrd1 Thioredoxin reductase 1, cytoplasmic (45279 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Plasma (328 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Grin1 Glutamate NMDA receptor (6467 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mycobacterium tuberculosis H37Rv (422 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
rpsR 30S ribosomal protein S18 (6 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ddl D-alanine--D-alanine ligase (5 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Streptomyces acidiscabies (73 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Streptomyces scabiei (197 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Streptomyces alboniger (61 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ftsA Cell division protein FtsA (3 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
erpA Iron-sulfur cluster insertion protein ErpA (3 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
tolC Outer membrane protein TolC (10 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
tsaE tRNA threonylcarbamoyladenosine biosynthesis protein TsaE (6 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SARS-CoV-2 (38078 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Names and Identifiers

Pubchem Sid488180025
Pubchem Sid Urlhttps://pubchem.ncbi.nlm.nih.gov/substance/488180025
IUPAC Name (4R)-4-amino-1,2-oxazolidin-3-one
INCHI InChI=1S/C3H6N2O2/c4-2-1-7-5-3(2)6/h2H,1,4H2,(H,5,6)/t2-/m1/s1
InChi Key DYDCUQKUCUHJBH-UWTATZPHSA-N
Canonical SMILES C1C(C(=O)NO1)N
Isomeric SMILES C1[C@H](C(=O)NO1)N
WGK Germany 2
RTECS NY2975000
Alternate CAS 68-41-7
PubChem CID 6234
NSC Number 756712
MeSH Entry Terms Cycloserine;R-4-Amino-3-isoxazolidinone;Seromycin
Molecular Weight 102.09
Beilstein 80798
Reaxy-Rn 80798

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

Find and download the COA for your product by matching the lot number on the packaging.

20 results found

Lot NumberCertificate TypeDateItem
G2429506Certificate of AnalysisJun 21, 2024 C108718
G2429505Certificate of AnalysisJun 21, 2024 C108718
G2429490Certificate of AnalysisJun 21, 2024 C108718
D2425252Certificate of AnalysisApr 15, 2024 C108718
D2425253Certificate of AnalysisApr 15, 2024 C108718
D2425255Certificate of AnalysisApr 15, 2024 C108718
B2328817Certificate of AnalysisApr 11, 2024 C108718
B2328786Certificate of AnalysisJan 12, 2024 C108718
B2328812Certificate of AnalysisDec 25, 2023 C108718
B2328814Certificate of AnalysisDec 25, 2023 C108718
L1912118Certificate of AnalysisDec 13, 2023 C108718
H2322242Certificate of AnalysisSep 02, 2023 C108718
H2322243Certificate of AnalysisSep 02, 2023 C108718
H2322244Certificate of AnalysisSep 02, 2023 C108718
H2322245Certificate of AnalysisSep 02, 2023 C108718
B2328816Certificate of AnalysisFeb 10, 2023 C108718
B2328815Certificate of AnalysisFeb 10, 2023 C108718
H2130339Certificate of AnalysisJun 23, 2022 C108718
H2130076Certificate of AnalysisJun 23, 2022 C108718
H2130077Certificate of AnalysisJun 23, 2022 C108718

Show more⌵

Chemical and Physical Properties

SolubilitySoluble in water. Slightly soluble in methanol and propylene glycol. Insoluble in chloroform and ether.
Sensitivityheat & air sensitive
Specific Rotation[α]+110 to +130 deg(C=1, H2O)
Melt Point(°C)147°C

Safety and Hazards(GHS)

Pictogram(s) GHS07
Signal Warning
Hazard Statements

H315:Causes skin irritation

H319:Causes serious eye irritation

H335:May cause respiratory irritation

H302:Harmful if swallowed

H332:Harmful if inhaled

Precautionary Statements

P261:Avoid breathing dust/fume/gas/mist/vapors/spray.

P305+P351+P338:IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present and easy to do - continue rinsing.

P280:Wear protective gloves/protective clothing/eye protection/face protection.

P302+P352:IF ON SKIN: wash with plenty of water.

P321:Specific treatment (see ... on this label).

P405:Store locked up.

P501:Dispose of contents/container to ...

P264:Wash hands [and …] thoroughly after handling.

P271:Use only outdoors or in a well-ventilated area.

P270:Do not eat, drink or smoke when using this product.

P304+P340:IF INHALED: Remove person to fresh air and keep comfortable for breathing.

P403+P233:Store in a well-ventilated place. Keep container tightly closed.

P362+P364:Take off contaminated clothing and wash it before reuse.

P330:Rinse mouth.

P264+P265:Wash hands [and …] thoroughly after handling. Do not touch eyes.

P301+P317:IF SWALLOWED: Get medical help.

P317:Get emergency medical help.

P337+P317:If eye irritation persists: Get medical help.

P332+P317:If skin irritation occurs: Get medical help.

P319:Get medical help if you feel unwell.

WGK Germany 2
RTECS NY2975000
Reaxy-Rn 80798
Merck Index 2751

Related Documents

Citations of This Product

1. Guan-Lan Huang, Ling Yang, Bo-Ying Ren, Xin-Yue Lv, Ling-Yi Song, Xia-Lin Dai, Jia-Mei Chen.  (2022)  Simultaneously improving the physicochemical and pharmacokinetic properties of vemurafenib through cocrystallization strategy.  JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY,  70  (103230).  [PMID:]

References

1. Shih PY et al..  (2020)  CTTNBP2 Controls Synaptic Expression of Zinc-Related Autism-Associated Proteins and Regulates Synapse Formation and Autism-like Behaviors..  Cell Rep,  31  (9): (107700).  [PMID:32492416]
2. Huang TN et al..  (2019)  Interhemispheric Connectivity Potentiates the Basolateral Amygdalae and Regulates Social Interaction and Memory..  Cell Rep,  29  (34-48.e4).  [PMID:31577954]
3. Warmus BA et al..  (2014)  Tau-mediated NMDA receptor impairment underlies dysfunction of a selectively vulnerable network in a mouse model of frontotemporal dementia..  J Neurosci,  34  (49): (16482-95).  [PMID:25471585]
4. Michael Davis,Kerry Ressler,Barbara O Rothbaum,Rick Richardson.  (2006-08-22)  Effects of D-cycloserine on extinction: translation from preclinical to clinical work..  Biological psychiatry,  60  ((4)): (369-375).  [PMID:16919524]
5. Michael W Otto,Shawnee L Basden,Teresa M Leyro,R Kathryn McHugh,Stefan G Hofmann.  (2006-12-29)  Clinical perspectives on the combination of D-cycloserine and cognitive-behavioral therapy for the treatment of anxiety disorders..  CNS spectrums,  12  ((1)): (51-56).  [PMID:17192764]
6. Stefan G Hofmann,Mark H Pollack,Michael W Otto.  (2007-01-18)  Augmentation treatment of psychotherapy for anxiety disorders with D-cycloserine..  CNS drug reviews,  12  ((3-4)): (208-217).  [PMID:17227287]
7. Rami Yaka,Anat Biegon,Nikolaos Grigoriadis,Constantina Simeonidou,Savvas Grigoriadis,Alexander G Alexandrovich,Henri Matzner,Johanna Schumann,Victoria Trembovler,Jeanna Tsenter,Esther Shohami.  (2007-03-14)  D-cycloserine improves functional recovery and reinstates long-term potentiation (LTP) in a mouse model of closed head injury..  FASEB journal : official publication of the Federation of American Societies for Experimental Biology,  21  ((9)): (2033-2041).  [PMID:17351125]
8. Panayotis K Thanos,Carlos Bermeo,Gene-Jack Wang,Nora D Volkow.  (2009-01-21)  D-cycloserine accelerates the extinction of cocaine-induced conditioned place preference in C57bL/c mice..  Behavioural brain research,  199  ((2)): (345-349).  [PMID:19152811]
9. Christian Grillon.  (2009-06-13)  D-cycloserine facilitation of fear extinction and exposure-based therapy might rely on lower-level, automatic mechanisms..  Biological psychiatry,  66  ((7)): (636-641).  [PMID:19520359]
10. Donald C Goff.  (2012-03-01)  D-cycloserine: an evolving role in learning and neuroplasticity in schizophrenia..  Schizophrenia bulletin,  38  ((5)): (936-941).  [PMID:22368237]
11. Karyn M Myers,William A Carlezon.  (2012-05-15)  D-cycloserine effects on extinction of conditioned responses to drug-related cues..  Biological psychiatry,  71  ((11)): (947-955).  [PMID:22579305]
12. Stefan G Hofmann,Alice T Sawyer,Anu Asnaani.  (2012-05-29)  D-cycloserine as an augmentation strategy for cognitive behavioral therapy for anxiety disorders: an update..  Current pharmaceutical design,  18  ((35)): (5659-5662).  [PMID:22632472]
13. Claus Normann,Christoph Nissen,Lukas Frase.  (2012-08-31)  Neuroenhancement strategies for psychiatric disorders: rationale, status quo and perspectives..  European archives of psychiatry and clinical neuroscience,  262 Suppl 2  (S113-S116).  [PMID:22932721]
14. A D Kalechstein,J H Yoon,J J Mahoney,T F Newton,L Chang,R De La Garza.  (2012-09-11)  d-Cycloserine administration does not affect neurocognition in concurrent cocaine- and nicotine-dependent volunteers..  Pharmacology, biochemistry, and behavior,  103  ((2)): (403-407).  [PMID:22960612]
15. Cassidy A Gutner,Joel Weinberger,Stefan G Hofmann.  (2012-09-21)  The effect of D-cycloserine on subliminal cue exposure in spider fearful individuals..  Cognitive behaviour therapy,  41  ((4)): (335-344).  [PMID:22992160]
16. Mikko Ylilauri,Olli T Pentikäinen.  (2012-10-19)  Structural mechanism of N-methyl-D-aspartate receptor type 1 partial agonism..  PloS one,  ((10)): (e47604-e47604).  [PMID:23077649]
17. Candyce D Tart,Pamela R Handelsman,Lindsey B Deboer,David Rosenfield,Mark H Pollack,Stefan G Hofmann,Mark B Powers,Michael W Otto,Jasper A J Smits.  (2012-10-27)  Augmentation of exposure therapy with post-session administration of D-cycloserine..  Journal of psychiatric research,  47  ((2)): (168-174).  [PMID:23098672]
18. V P Nikitin,S V Solntseva.  (2012-11-01)  Mechanisms of amnesia induced by impairment of long-term memory reconsolidation in edible snail..  Bulletin of experimental biology and medicine,  153  ((5)): (609-613).  [PMID:23113237]
19. J Peters,T J De Vries.  (2012-11-20)  D-cycloserine administered directly to infralimbic medial prefrontal cortex enhances extinction memory in sucrose-seeking animals..  Neuroscience,  230  (24-30).  [PMID:23159319]
20. Majid Moridani,Tracy Scott.  (2013-01-02)  Lookalike, soundalike tests: preventing serious medical errors..  Archives of pathology & laboratory medicine,  137  ((1)): (11-11).  [PMID:23276168]
21. Gareth A Prosser,Luiz Pedro S de Carvalho.  (2013-01-05)  Kinetic mechanism and inhibition of Mycobacterium tuberculosis D-alanine:D-alanine ligase by the antibiotic D-cycloserine..  The FEBS journal,  280  ((4)): (1150-1166).  [PMID:23286234]
22. Srinivasa Rao Polagani,Nageswara Rao Pilli,Rambabu Maddela,Ramakrishna Gajula,Venkateswarlu Gandu.  (2013-01-08)  A rapid and sensitive liquid chromatography-tandem mass spectrometric assay for cycloserine in 50μL of human plasma: Its pharmacokinetic application..  Journal of pharmaceutical and biomedical analysis,  76  (21-27).  [PMID:23291439]
23. Dinko Kranjac,Kyle M Koster,Marielle S Kahn,Micah J Eimerbrink,Brent M Womble,Brenton G Cooper,Michael J Chumley,Gary W Boehm.  (2013-01-09)  Peripheral administration of D-cycloserine rescues memory consolidation following bacterial endotoxin exposure..  Behavioural brain research,  243  (38-43).  [PMID:23295393]
24. Gary Baisa,Nicholas J Stabo,Rodney A Welch.  (2013-01-15)  Characterization of Escherichia coli D-cycloserine transport and resistant mutants..  Journal of bacteriology,  195  ((7)): (1389-1399).  [PMID:23316042]
25. Kosuke Oda,Yasuyuki Matoba,Takanori Kumagai,Masafumi Noda,Masanori Sugiyama.  (2013-02-12)  Crystallographic study to determine the substrate specificity of an L-serine-acetylating enzyme found in the D-cycloserine biosynthetic pathway..  Journal of bacteriology,  195  ((8)): (1741-1749).  [PMID:23396912]
26. Kerry C Carson,Lusiana V Boseiwaqa,Sara K Thean,Niki F Foster,Thomas V Riley.  (2013-04-13)  Isolation of Clostridium difficile from faecal specimens--a comparison of chromID C. difficile agar and cycloserine-cefoxitin-fructose agar..  Journal of medical microbiology,  62  ((Pt 9)): (1423-1427).  [PMID:23579394]
27. Thomas L Rodebaugh,Eric J Lenze.  (2013-05-10)  Lessons learned from D-cycloserine: the promise and limits of drug facilitation of exposure therapy..  The Journal of clinical psychiatry,  74  ((4)): (415-416).  [PMID:23656850]
28. Kerin L Tyrrell,Diane M Citron,Eliza S Leoncio,C Vreni Merriam,Ellie J C Goldstein.  (2013-06-28)  Evaluation of cycloserine-cefoxitin fructose agar (CCFA), CCFA with horse blood and taurocholate, and cycloserine-cefoxitin mannitol broth with taurocholate and lysozyme for recovery of Clostridium difficile isolates from fecal samples..  Journal of clinical microbiology,  51  ((9)): (3094-3096).  [PMID:23804392]
29. Daniel C Javitt.  (2013-07-04)  Harnessing N-methyl-d-aspartate receptors for new treatment development in psychiatry: positive lessons from negative studies..  The American journal of psychiatry,  170  ((7)): (699-702).  [PMID:23820828]
30. Geetha Ramachandran,Vedachalam Chandrasekaran,Agibothu Kupparam Hemanth Kumar,Puneet Dewan,Soumya Swaminathan,Aleyamma Thomas.  (2013-08-14)  Estimation of content of anti-TB drugs supplied at centres of the Revised National TB Control Programme in Tamil Nadu, India..  Tropical medicine & international health : TM & IH,  18  ((9)): (1141-1144).  [PMID:23937703]
31. Gareth A Prosser,Luiz Pedro S de Carvalho.  (2013-09-17)  Reinterpreting the mechanism of inhibition of Mycobacterium tuberculosis D-alanine:D-alanine ligase by D-cycloserine..  Biochemistry,  52  ((40)): (7145-7149).  [PMID:24033232]
32. Amy Rapp,Alice Dodds,John T Walkup,Moira Rynn.  (2013-11-28)  Treatment of pediatric anxiety disorders..  Annals of the New York Academy of Sciences,  1304  (52-61).  [PMID:24279893]
33. Elena Venir,Manuela Del Torre,Vincenzo Cunsolo,Rosaria Saletti,Rita Musetti,Mara Lucia Stecchini.  (2013-12-19)  Involvement of alanine racemase in germination of Bacillus cereus spores lacking an intact exosporium..  Archives of microbiology,  196  ((2)): (79-85).  [PMID:24346000]
34. Kristin N Adams,John D Szumowski,Lalita Ramakrishnan.  (2014-02-18)  Verapamil, and its metabolite norverapamil, inhibit macrophage-induced, bacterial efflux pump-mediated tolerance to multiple anti-tubercular drugs..  The Journal of infectious diseases,  210  ((3)): (456-466).  [PMID:24532601]
35. Yasuhiro Horita,Norio Doi.  (2014-03-26)  Comparative study of the effects of antituberculosis drugs and antiretroviral drugs on cytochrome P450 3A4 and P-glycoprotein..  Antimicrobial agents and chemotherapy,  58  ((6)): (3168-3176).  [PMID:24663015]
36. Menglin Ma,Abhijit Gurjar,James R Theoret,Jorge P Garcia,Juliann Beingesser,John C Freedman,Derek J Fisher,Bruce A McClane,Francisco A Uzal.  (2014-04-30)  Synergistic effects of Clostridium perfringens enterotoxin and beta toxin in rabbit small intestinal loops..  Infection and immunity,  82  ((7)): (2958-2970).  [PMID:24778117]
37. Hyo-Ji Kim,Kyung-Ah Seo,Hyun-Mi Kim,Eun-Sook Jeong,Jong Lyul Ghim,Seung Heon Lee,Young Min Lee,Dong Hyun Kim,Jae-Gook Shin.  (2014-09-15)  Simple and accurate quantitative analysis of 20 anti-tuberculosis drugs in human plasma using liquid chromatography-electrospray ionization-tandem mass spectrometry..  Journal of pharmaceutical and biomedical analysis,  102  (9-16).  [PMID:25218029]
38. Ram Maharjan,Thomas Ferenci.  (2014-11-13)  Mutational signatures indicative of environmental stress in bacteria..  Molecular biology and evolution,  32  ((2)): (380-391).  [PMID:25389207]
39. Stefan G Hofmann,Michael W Otto,Mark H Pollack,Jasper A Smits.  (2014-11-22)  D-cycloserine augmentation of cognitive behavioral therapy for anxiety disorders: an update..  Current psychiatry reports,  17  ((1)): (532-532).  [PMID:25413638]
40. J Watkins,D P Sartory.  (2014-12-18)  Evaluation of a membrane filtration method for the rapid enumeration of confirmed Clostridium perfringens from water..  Letters in applied microbiology,  60  ((4)): (367-371).  [PMID:25514882]
41. Simon P Byrne,Ronald M Rapee,Rick Richardson,Gin S Malhi,Michael Jones,Jennifer L Hudson.  (2015-03-17)  D-cycloserine enhances generalization of fear extinction in children..  Depression and anxiety,  32  ((6)): (408-414).  [PMID:25775435]
42. Lihua Zhang,Danfeng Dong,Cen Jiang,Zhen Li,Xuefeng Wang,Yibing Peng.  (2015-03-31)  Insight into alteration of gut microbiota in Clostridium difficile infection and asymptomatic C. difficile colonization..  Anaerobe,  34  (1-7).  [PMID:25817005]
43. G V Jakobsen,B B Jensen,K E Bach Knudsen,N Canibe.  (2015-05-29)  Fermentation and addition of enzymes to a diet based on high-moisture corn, rapeseed cake, and peas improve digestibility of nonstarch polysaccharides, crude protein, and phosphorus in pigs..  Journal of animal science,  93  ((5)): (2234-2245).  [PMID:26020320]
44. Yoshihiko Shimokawa,Noriaki Yoda,Satoshi Kondo,Yoshiya Yamamura,Yoshiharu Takiguchi,Ken Umehara.  (2015-06-23)  Inhibitory Potential of Twenty Five Anti-tuberculosis Drugs on CYP Activities in Human Liver Microsomes..  Biological & pharmaceutical bulletin,  38  ((9)): (1425-1429).  [PMID:26094899]
45. Wafaa Jamal,Eunice Pauline,Vincent Rotimi.  (2015-07-07)  A prospective study of community-associated Clostridium difficile infection in Kuwait: Epidemiology and ribotypes..  Anaerobe,  35  ((Pt B)): (28-32).  [PMID:26144314]
46. Amanda M King,Kathleen A Glass,Andrew L Milkowski,Jeffrey J Sindelar.  (2015-07-30)  Comparison of the Effect of Curing Ingredients Derived from Purified and Natural Sources on Inhibition of Clostridium perfringens Outgrowth during Cooling of Deli-Style Turkey Breast..  Journal of food protection,  78  ((8)): (1527-1535).  [PMID:26219366]
47. Rick Richardson,Lana Ledgerwood,Jacquelyn Cranney.  (2004-10-07)  Facilitation of fear extinction by D-cycloserine: theoretical and clinical implications..  Learning & memory (Cold Spring Harbor, N.Y.),  11  ((5)): (510-516).  [PMID:15466301]
48. Erica J Duncan,Sandor Szilagyi,Marion P Schwartz,Dragana Bugarski-Kirola,Alena Kunzova,Shobhit Negi,Myrsini Stephanides,Toby R Efferen,Burt Angrist,Eric Peselow,June Corwin,Stephen Gonzenbach,John P Rotrosen.  (2004-10-12)  Effects of D-cycloserine on negative symptoms in schizophrenia..  Schizophrenia research,  71  ((2-3)): (239-248).  [PMID:15474895]
49. Bram Vervliet.  (2007-08-21)  Learning and memory in conditioned fear extinction: effects of D-cycloserine..  Acta psychologica,  127  ((3)): (601-613).  [PMID:17707326]
50. Barbara Olasov Rothbaum.  (2008-03-05)  Critical parameters for D-cycloserine enhancement of cognitive-behaviorial therapy for obsessive-compulsive disorder..  The American journal of psychiatry,  165  ((3)): (293-296).  [PMID:18316423]
51. Lisa J Heaton,Daniel W McNeil,Peter Milgrom.  (2010-02-16)  Propranolol and D-cycloserine as adjunctive medications in reducing dental fear in sedation practice..  SAAD digest,  26  (27-35).  [PMID:20151608]
52. Mary M Torregrossa,Hayde Sanchez,Jane R Taylor.  (2010-08-06)  D-cycloserine reduces the context specificity of pavlovian extinction of cocaine cues through actions in the nucleus accumbens..  The Journal of neuroscience : the official journal of the Society for Neuroscience,  30  ((31)): (10526-10533).  [PMID:20685995]
53. Wen-Xiao Tian,Shi Yu,Muhammad Ibrahim,Abdul Wareth Almonaofy,Liu He,Qiu Hui,Zhu Bo,Bin Li,Guan-Lin Xie.  (2012-08-28)  Copper as an antimicrobial agent against opportunistic pathogenic and multidrug resistant Enterobacter bacteria..  Journal of microbiology (Seoul, Korea),  50  ((4)): (586-593).  [PMID:22923106]
54. Kathryn D Baker,Gavan P McNally,Rick Richardson.  (2012-09-18)  D-cycloserine does not facilitate fear extinction by reducing conditioned stimulus processing or promoting conditioned inhibition to contextual cues..  Learning & memory (Cold Spring Harbor, N.Y.),  19  ((10)): (461-469).  [PMID:22984284]
55. Kenichi Kuriyama,Motoyasu Honma,Takuya Yoshiike,Yoshiharu Kim.  (2012-09-21)  Valproic acid but not D-cycloserine facilitates sleep-dependent offline learning of extinction and habituation of conditioned fear in humans..  Neuropharmacology,  64  (424-431).  [PMID:22992332]
56. Andrea M Nave,David F Tolin,Michael C Stevens.  (2012-10-13)  Exposure therapy, D-cycloserine, and functional magnetic resonance imaging in patients with snake phobia: a randomized pilot study..  The Journal of clinical psychiatry,  73  ((9)): (1179-1186).  [PMID:23059145]
57. Irene Villarejo-Rodríguez,Pere Boadas-Vaello,Marta Portero-Tresserra,Anna Vale-Martínez,Margarita Martí-Nicolovius,Gemma Guillazo-Blanch.  (2012-11-06)  Learning deficits in an odor reward-task induced by parafascicular thalamic lesions are ameliorated by pretraining D-cycloserine in the prelimbic cortex..  Behavioural brain research,  238  (289-292).  [PMID:23124092]
58. Yasuhiro Saito,Machiko Matsumoto,Yoshiki Yanagawa,Sachiko Hiraide,Sumiyoshi Inoue,Yasunori Kubo,Kei-Ichi Shimamura,Hiroko Togashi.  (2012-11-16)  Facilitation of fear extinction by the 5-HT(1A) receptor agonist tandospirone: possible involvement of dopaminergic modulation..  Synapse (New York, N.Y.),  67  ((4)): (161-170).  [PMID:23152167]
59. Marta Portero-Tresserra,Margarita Martí-Nicolovius,Gemma Guillazo-Blanch,Pere Boadas-Vaello,Anna Vale-Martínez.  (2012-12-04)  D-cycloserine in the basolateral amygdala prevents extinction and enhances reconsolidation of odor-reward associative learning in rats..  Neurobiology of learning and memory,  100  (1-11).  [PMID:23200640]
60. Roopali Yadav,Brandon G Hillman,Subhash C Gupta,Pratyush Suryavanshi,Jay M Bhatt,Ratnamala Pavuluri,Dustin J Stairs,Shashank M Dravid.  (2013-04-06)  Deletion of glutamate delta-1 receptor in mouse leads to enhanced working memory and deficit in fear conditioning..  PloS one,  ((4)): (e60785-e60785).  [PMID:23560106]
61. Stefan G Hofmann,Jasper A J Smits,David Rosenfield,Naomi Simon,Michael W Otto,Alicia E Meuret,Luana Marques,Angela Fang,Candyce Tart,Mark H Pollack.  (2013-04-20)  D-Cycloserine as an augmentation strategy with cognitive-behavioral therapy for social anxiety disorder..  The American journal of psychiatry,  170  ((7)): (751-758).  [PMID:23599046]
62. L O Melkonian,G E Avetisova,A A Ambartsumian,A Kh Chakhalian,A S Sagian.  (2013-06-26)  [Regulation of key enzymes of L-alanine biosynthesis by Brevibacterium flavum producer strains]..  Prikladnaia biokhimiia i mikrobiologiia,  49  ((2)): (144-148).  [PMID:23795472]
63. R M Thomson,C E Tolson,R Carter,F Huygens,M Hargreaves.  (2014-01-09)  Heterogeneity of clinical and environmental isolates of Mycobacterium fortuitum using repetitive element sequence-based PCR: municipal water an unlikely source of community-acquired infections..  Epidemiology and infection,  142  ((10)): (2057-2064).  [PMID:24398184]
64. Kanthi Kiran Kondepudi,Padma Ambalam,Peren H Karagin,Ingrid Nilsson,Torkel Wadström,Åsa Ljungh.  (2014-07-26)  A novel multi-strain probiotic and synbiotic supplement for prevention of Clostridium difficile infection in a murine model..  Microbiology and immunology,  58  ((10)): (552-558).  [PMID:25059277]
65. Vélvá M Combs,Heather D Crispell,Kelly L Drew.  (2014-08-08)  D-cycloserine 24 and 48\u2009hours after asphyxial cardiac arrest has no effect on hippocampal CA1 neuropathology..  Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism,  34  ((10)): (doi:10-doi:10).  [PMID:25099755]
66. Wei-Jia Fang,Da-Zhi Jing,Yun Luo,Cai-Yun Fu,Peng Zhao,Jiong Qian,Bing-Ru Tian,Xiao-Gang Chen,Yu-Long Zheng,Yi Zheng,Jing Deng,Wei-Hua Zou,Xue-Ren Feng,Fan-Long Liu,Xiao-Zhou Mou,Shu-Sen Zheng.  (2014-10-01)  Clostridium difficile carriage in hospitalized cancer patients: a prospective investigation in eastern China..  BMC infectious diseases,  14  (523-523).  [PMID:25267108]
67. Michael L Sulkowski,Daniel A Geller,Adam B Lewin,Tanya K Murphy,Andrew Mittelman,Ashley Brown,Eric A Storch.  (2014-11-11)  The Future of D-Cycloserine and Other Cognitive Modifiers in Obsessive-Compulsive and Related Disorders..  Current psychiatry reviews,  10  ((4)): (317-324).  [PMID:25383074]
68. Marta Portero-Tresserra,Nuria Del Olmo,Margarita Martí-Nicolovius,Gemma Guillazo-Blanch,Anna Vale-Martínez.  (2014-12-03)  D-cycloserine prevents relational memory deficits and suppression of long-term potentiation induced by scopolamine in the hippocampus..  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology,  24  ((11)): (1798-1807).  [PMID:25453488]
69. Danielle L Sexton,Renée J St-Onge,Henry J Haiser,Mary R Yousef,Lauren Brady,Chan Gao,Jacqueline Leonard,Marie A Elliot.  (2014-12-17)  Resuscitation-promoting factors are cell wall-lytic enzymes with important roles in the germination and growth of Streptomyces coelicolor..  Journal of bacteriology,  197  ((5)): (848-860).  [PMID:25512314]
70. Azusa Sugiyama,Akiyoshi Saitoh,Masatoshi Inagaki,Jun-Ichiro Oka,Mitsuhiko Yamada.  (2015-06-28)  Systemic administration of riluzole enhances recognition memory and\xa0facilitates extinction of fear memory in rats..  Neuropharmacology,  97  (322-328).  [PMID:26116528]
71. Alex Rodriguez-Palacios,Tomohiro Kodani,Lindsey Kaydo,Davide Pietropaoli,Daniele Corridoni,Scott Howell,Jeffry Katz,Wei Xin,Theresa T Pizarro,Fabio Cominelli.  (2015-07-15)  Stereomicroscopic 3D-pattern profiling of murine and human intestinal inflammation reveals unique structural phenotypes..  Nature communications,  (7577-7577).  [PMID:26154811]
72. Guan-Lan Huang, Ling Yang, Bo-Ying Ren, Xin-Yue Lv, Ling-Yi Song, Xia-Lin Dai, Jia-Mei Chen.  (2022)  Simultaneously improving the physicochemical and pharmacokinetic properties of vemurafenib through cocrystallization strategy.  JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY,  70  (103230).  [PMID:]

Solution Calculators